Peer-reviewedCC BYFrontiers in oncology
Ginsenoside Rb2 promotes p62-mediated LDHA autophagic degradation to inhibit H3K18la-dependent PD-L1 transcription in cervical cancer
5 affiliations
- 1Department of Gynecology, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine , ,
- 2Department of Gynecology, Nanjing Women and Children’s Healthcare Hospital, Women’s Hospital of Nanjing Medical University , , ,
- 3School of Traditional Chinese Medicine, Faculty of Medicine, Yangzhou University , ,
- 4Department of Obstetrics and Gynecology, The Affiliated Hospital of Yangzhou University , ,
- 5Jiangsu Cancer Hospital, The Affiliated Cancer Hospital of Nanjing Medical University , , ,
Related
- Deficiency of non-muscle myosin IIA promotes neuroinflammation by impairing autophagic degradation of VCAM-1 in brain endothelium
- Knockdown of Smurf1 Promotes Autophagy-Dependent Ferroptosis in Acute Liver Failure by Inhibiting Ubiquitin-Mediated Ulk1 Degradation.
- A multi-subunit autophagic capture complex facilitates degradation of ER-stalled MHC class I in pancreatic cancer
- ATG13 Recruits LC3 to Target H9N2-IAV PB1 for Autophagic-Lysosomal Degradation and Restricts Viral Replication
- Roles of vacuolar proteases in the autophagic degradation of nuclei and other substrates in Aspergillus oryzae
BibTeX
@article{wang2026ginsenoside,
title = {{Ginsenoside Rb2 promotes p62-mediated LDHA autophagic degradation to inhibit H3K18la-dependent PD-L1 transcription in cervical cancer}},
author = {Xingwei Wang and Ziyue Zhang and Mei Chen and Liu Luo and Ru Sun and Chen Chen and Minmin Yu},
journal = {Frontiers in oncology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13654782},
note = {CC BY},
}
RIS
TY - JOUR
TI - Ginsenoside Rb2 promotes p62-mediated LDHA autophagic degradation to inhibit H3K18la-dependent PD-L1 transcription in cervical cancer
AU - Xingwei Wang
AU - Ziyue Zhang
AU - Mei Chen
AU - Liu Luo
AU - Ru Sun
AU - Chen Chen
AU - Minmin Yu
PY - 2026
DA - 2026/10/16
JO - Frontiers in oncology
UR - https://europepmc.org/article/PMC/PMC13654782
SN - 2234-943X
ER -